Cystatin C in a high-risk combination

Circ J. 2009 Sep;73(9):1593-4. doi: 10.1253/circj.cj-09-0351.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Angioplasty, Balloon, Coronary* / adverse effects
  • Angioplasty, Balloon, Coronary* / mortality
  • Biomarkers / blood
  • Cardiovascular Diseases / blood
  • Cardiovascular Diseases / etiology
  • Creatinine / blood
  • Cystatin C / blood*
  • Glomerular Filtration Rate
  • Hospital Mortality
  • Humans
  • Myocardial Infarction / blood
  • Myocardial Infarction / complications
  • Myocardial Infarction / mortality
  • Myocardial Infarction / therapy*
  • Patient Readmission
  • Predictive Value of Tests
  • ROC Curve
  • Recurrence
  • Renal Insufficiency / blood
  • Renal Insufficiency / complications*
  • Renal Insufficiency / mortality
  • Renal Insufficiency / physiopathology
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome

Substances

  • Biomarkers
  • CST3 protein, human
  • Cystatin C
  • Creatinine